Table 3.
Patient-Reported Barriers with Follow-Up of Abnormal Screening Results
| Agree or strongly agree, N (%) | All (n = 241) | Cancer type | Completed follow-up within 120 days | |||||
|---|---|---|---|---|---|---|---|---|
| Breast (n = 66) | Cervical (n = 79) | Colorectal (n = 96) | p-value | No (n = 123) | Yes (n = 118) | p-value | ||
| I worried about whether the test would find cancerb | 152 (63.1%) | 48 (72.7%) | 58 (73.4%) | 46 (47.9%) | < 0.001* | 70 (56.9%) | 82 (69.5%) | 0.046 |
| I worried about discomfort or a side effect from the test | 83 (34.4%) | 23 (34.8%) | 37 (46.8%) | 23 (24.0%) | 0.006* | 43 (35.0%) | 40 (33.9%) | 0.89 |
| I worried about the costs of the test or appointmenta | 46 (19.3%) | 15 (23.4%) | 13 (16.7%) | 18 (18.8%) | 0.60 | 28 (23.0%) | 18 (15.5%) | 0.19 |
| I didn’t think I needed any more tests or appointments | 41 (17.4%) | 8 (12.7%) | 13 (16.9%) | 20 (21.1%) | 0.39 | 29 (24.0%) | 12 (10.5%) | 0.009* |
Question wording: “Thinking about the workup that was recommended to you after your [cancer_screening] result, please indicate how much you agree or disagree with each of the following statements:” All comparisons were conducted using Fisher’s exact test
*Remains significant after adjustment for multiple testing, allowing for a family-wise Bonferroni adjustment for four tests